Intimate Bridge 2 Conception, Inc. (Ib2C™), a Pittsburgh-based direct-to-consumer medical device company focused on reproductive health, has closed a $4.3m Series A financing.
The round was led by a private, Pennsylvania-based investment group and was joined by the PLSG Accelerator Fund.
The company intends to use the capital for manufacturing and marketing to prepare for the launch of its first product in 2012.
Led by Founder and CEO Steve Bollinger, Ib2C™ is developing healthcare products designed to assist women and couples to achieve their reproductive goals. Its lead product, the Stork™, is a proprietary device – currently being evaluated by the FDA for safety and effectiveness – intended to assist couples with conception in the privacy of their own homes. It is a non-pharmaceutical product that will provide couples with an alternative to Assisted Reproductive Technology (ART).